📰 Conmed Co News
Conmed Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Conmed Co. Real-time updates on events, politics, business and more.
April 2, 2024
CONMED Co. (NYSE:CNMD – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven analysts that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target […]
March 13, 2024
CONMED Co. (NYSE:CNMD – Get Free Report) declared a quarterly dividend on Monday, February 26th, Wall Street Journal reports. Stockholders of record on Friday, March 15th will be paid a dividend of 0.20 per share on Friday, April 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.94%. The […]
February 1, 2024
Research Analysts’ price target changes for Thursday, February 1st: Align Technology (NASDAQ:ALGN) had its target price boosted by Piper Sandler from $290.00 to $335.00. The firm currently has an overweight rating on the stock. Aptose Biosciences (NASDAQ:APTO) (TSE:APS) had its price target trimmed by Piper Sandler from $12.00 to $5.00. They currently have an overweight […]
January 18, 2024
CONMED Co. (NYSE:CNMD – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price objective among […]
December 26, 2023
CONMED Co. (NYSE:CNMD – Get Free Report) has received an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year target […]
November 1, 2023
Stock Analysts’ upgrades for Wednesday, November 1st: Aeglea BioTherapeutics (NASDAQ:AGLE) was upgraded by analysts at StockNews.com from a sell rating to a hold rating. Amazon.com (NASDAQ:AMZN) was upgraded by analysts at StockNews.com from a hold rating to a buy rating. AutoZone (NYSE:AZO) was upgraded by analysts at StockNews.com from a hold rating to a buy […]
October 12, 2023
CONMED Co. (NYSE:CNMD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five research firms that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1 year price […]
August 18, 2023
CONMED Co. (NYSE:CNMD – Get Free Report) CFO Todd W. Garner sold 1,355 shares of the company’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $112.00, for a total transaction of $151,760.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, […]
August 13, 2023
CONMED Co. (NYSE:CNMD – Free Report) – Stock analysts at Zacks Research raised their Q3 2023 earnings per share estimates for CONMED in a report released on Wednesday, August 9th. Zacks Research analyst I. Bandyopadhyay now forecasts that the company will post earnings per share of $0.82 for the quarter, up from their previous forecast […]
July 21, 2023
CONMED Co. (NYSE:CNMD – Get Free Report) shares traded down 4.6% during mid-day trading on Friday . The stock traded as low as $126.00 and last traded at $126.00. 263,339 shares changed hands during trading, a decline of 31% from the average session volume of 383,658 shares. The stock had previously closed at $132.13. Wall […]